2007
DOI: 10.1128/cvi.00214-07
|View full text |Cite
|
Sign up to set email alerts
|

European Multicenter Evaluation of Commercial Enzyme Immunoassays for Detecting Norovirus Antigen in Fecal Samples

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
49
2
1

Year Published

2008
2008
2023
2023

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 90 publications
(53 citation statements)
references
References 22 publications
1
49
2
1
Order By: Relevance
“…Of these, one sample showed inhibition of the PCR and was excluded. Of the remaining 537 samples, 98 (18.2%) were PCR-positive and 60 (11.2%) were positive by the RQN assay (Table 1) and 96%, which are more consistent with our findings for the RQN assay [7][8][9][10]. The difference between Apostel's and our RQN assay sensitivity results may be explained by differences between the two patient populations, the prevalent viral genotypes in these populations and the stage of infection at which sampling took place.…”
Section: Introductionsupporting
confidence: 81%
“…Of these, one sample showed inhibition of the PCR and was excluded. Of the remaining 537 samples, 98 (18.2%) were PCR-positive and 60 (11.2%) were positive by the RQN assay (Table 1) and 96%, which are more consistent with our findings for the RQN assay [7][8][9][10]. The difference between Apostel's and our RQN assay sensitivity results may be explained by differences between the two patient populations, the prevalent viral genotypes in these populations and the stage of infection at which sampling took place.…”
Section: Introductionsupporting
confidence: 81%
“…Current EIAs are based on polyclonal or monoclonal antibodies raised against a panel of different virus-like particles (VLPs). Previous studies have demonstrated that the sensitivity and specificity of NoV EIAs vary with the diagnostic goal (outbreak or sporadic cases) and test design (19), which raises questions about their usefulness for routine screening of samples.…”
mentioning
confidence: 99%
“…Advantages of EIA testing over PCR based assays include simplicity (no specialized equipment or skilled personnel required) and speed (rapid bed-side tests have been developed based on an EIA that promise results within 15 minutes). The EIAs use either monoclonal or polyclonal antibodies specific for a limited number of antigenically-distinct NoV genotypes, which can be problematic in the detection of antigenic variants or emerging genotypes (Gray et al, 2007). Knowledge of the local circulating NoV genotypes is helpful in evaluating the efficiency of the EIA in a particular setting (de Bruin et al, 2006).…”
Section: Detection Of Viruses In Humansmentioning
confidence: 99%